About Index Trending news
Analyze
Top 50 Pricing
Viroblock

Viroblock

Work at Viroblock? Add yourself to this profile

Viroblock

We develop antiviral technology. New respiratory mask traps and kills immediately more than 99.9995% of influenza H1N1.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital (Series C)
$3,600,000
Employees

Team size

2
Locations
HQ
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Viroblock makes some noise.